• Gyasi Moscou-Jackson, Jerilyn Allen, Sharon Kozachik, Michael T Smith, Chakra Budhathoki, and Carlton Haywood.
• Johns Hopkins University School of Nursing, Baltimore, MD. Electronic address: gmoscou1@jhu.edu.
• Pain Manag Nurs. 2016 Feb 1; 17 (1): 384638-46.

AbstractNo studies to date have systematically investigated insomnia symptoms among adults with sickle cell disease (SCD). The purpose of this study was to (1) describe the prevalence of insomnia symptoms and (2) identify biopsychosocial predictors in community-dwelling adults with SCD. Cross-sectional analysis of baseline data from 263 African American adults with SCD (aged 18 years or older). Measures included the Insomnia Severity Index (ISI), Center for Epidemiologic Studies in Depression scale, Urban Life Stress Scale, Brief Pain Inventory, and a chronic pain item. SCD genotype was extracted from the medical record. A slight majority (55%) of the sample reported clinically significant insomnia symptomatology (ISI ≥ 10), which suggests that insomnia symptoms are prevalent among community-dwelling African American adults with SCD. While insomnia symptoms were associated with a number of biopsychosocial characteristics, depressive symptoms and acute pain were the only independent predictors. Given the high number of participants reporting clinically significant insomnia symptoms, nurses should screen for insomnia symptoms and explore interventions to promote better sleep among adults with SCD, with an emphasis on recommending treatment for pain and depression. In addition, current pain and depression interventions in this population could add insomnia measures and assess the effect of the intervention on insomnia symptomatology as a secondary outcome.Copyright © 2016 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.

21 keywords...

hide…